Ken Fisher’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-81,949
Closed -$761K 1070
2025
Q2
$761K Hold
81,949
﹤0.01% 725
2025
Q1
$799K Buy
81,949
+4,286
+6% +$53K ﹤0.01% 719
2024
Q4
$940K Hold
77,663
﹤0.01% 665
2024
Q3
$851K Hold
77,663
﹤0.01% 679
2024
Q2
$699K Hold
77,663
﹤0.01% 728
2024
Q1
$635K Hold
77,663
﹤0.01% 746
2023
Q4
$655K Buy
77,663
+21,267
+38% +$247K ﹤0.01% 740
2023
Q3
$965K Hold
56,396
﹤0.01% 749
2023
Q2
$1.31M Sell
56,396
-6,283
-10% -$123K ﹤0.01% 726
2023
Q1
$1.11M Sell
62,679
-7,405
-11% -$176K ﹤0.01% 761
2022
Q4
$1.91M Buy
70,084
+14,826
+27% +$308K ﹤0.01% 654
2022
Q3
$954K Buy
+55,258
New +$1.05M ﹤0.01% 678

Other funds holding REPL

Ken Fisher's REPL Position: Q3 2025 in Review

Ken Fisher sold out of Replimune Group (REPL) in Q3 2025, closing a stake of 81,949 shares — an estimated $761K sold.

Ken Fisher first reported a position in REPL in Q3 2022 and held it in 12 quarters. The position peaked at $1.91M in Q4 2022. 163 funds tracked by Wall St. Rank hold REPL as of Q3 2025.

  • Ken Fisher reported no remaining Replimune Group position as of Q3 2025 after selling out during the quarter.
  • Ken Fisher sold 81,949 Replimune Group shares in Q3 2025, an estimated $761K.
  • Ken Fisher first reported a position in Replimune Group in Q3 2022 and held it in 12 quarters.
  • Ken Fisher's Replimune Group position peaked at $1.91M in Q4 2022.
  • 163 funds tracked by Wall St. Rank held Replimune Group as of Q3 2025.

Based on Fisher Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.